Daniel S. Chen
2020
In 2020, Daniel S. Chen earned a total compensation of $2.2M as Chief Medical Officer at IGM Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $219,000 |
|---|---|
| Option Awards | $1,559,063 |
| Salary | $456,250 |
| Total | $2,234,313 |
Chen received $1.6M in option awards, accounting for 70% of the total pay in 2020.
Chen also received $219K in non-equity incentive plan and $456.3K in salary.
Rankings
In 2020, Daniel S. Chen's compensation ranked 5,025th out of 13,090 executives tracked by ExecPay. In other words, Chen earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,025 out of 13,090 | 62nd |
Division Manufacturing | 2,052 out of 5,618 | 64th |
Major group Chemicals And Allied Products | 818 out of 2,251 | 64th |
Industry group Drugs | 707 out of 1,951 | 64th |
Industry Pharmaceutical Preparations | 532 out of 1,456 | 64th |
Source: SEC filing on April 29, 2021.
Chen's colleagues
We found two more compensation records of executives who worked with Daniel S. Chen at IGM Biosciences in 2020.